India Cancer Treatment Market Analysis, 2020

India Cancer Treatment Market Analysis, 2020

By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Other Treatment Types), By Type (Blood Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Prostate Cancer, G Read more

  • Healthcare
  • May 2020
  • 132
  • HC22018

India Cancer Treatment Market Analysis, 2020 market research report depicts a deep-dive market analysis and statistics of India Cancer Treatment Market. The research study provides regional and country-wise market size, market forecast, CAGR market segmentation, market shares of regions, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.

Continuous growth in the cancer cases owing to changing eating habits, food adulteration, environmental changes, growth in chemical establishments, etc. are the major factors for escalating cancer cases in India. The sedentary lifestyle and excessive intake of junk food have been leading to an increase in the number of cancer patients day by day. Moreover, the consumption of tobacco in the country is burgeoning, thereby mounting the total number of deaths due to tobacco cancer It is estimated that one woman dies of cervical cancer every 8 minutes in India due to cancer, according to the National Institute of Cancer Prevention and Research. Of every two women newly diagnosed with breast cancer, one woman dies of it in India.

According to MarkNtel Advisors’ research report titled “India Cancer Treatment Market Analysis, 2020”, the India Cancer Treatment Market is anticipated to grow at a substantial CAGR during 2020-25. The total number of deaths due to cancer in India were more than 0.8 million in 2019. 

Owing to extensive investments in R&D and a rise in cancer awareness among individuals, the need for timely diagnosis and preventive care is surging at an exponential pace. Additionally, India has witnessed remarkable opportunities for the venture capitalists and investors, as the developed markets are comparatively saturated in this industry. 

The cancer incidence rates in several states of India such as Madhya Pradesh, Odisha, Assam, Uttarakhand, Himachal Pradesh, Punjab, Haryana, Delhi, Maharashtra, Karnataka, etc., was above 82% in 2020. It has been found that lip, oral, breast, and cervical cancer treatment acquired more than 50% of the market share in 2019, as stated in MarkNtel Advisors’ research report “India Cancer Treatment Market Analysis, 2020”.  

 

Immunotherapy Segment Attaining Considerable Growth

The targeted therapy segment attained the largest market growth during 2015-19. This is due to the ability of targeted therapies to kill malignant cells only, advanced efficacy, and higher survival rates associated with their use. The immunotherapy segment is expected to show the fastest growth during the forecast period 2020-25. This is associated with intensification in the incidences of cancer in India and the lack of related medical assistance in the country. 

According to MarkNtel Advisors, the key players with a considerable market share in the India Cancer Treatment market include Amgen, AstraZeneca Plc, Merck and Co., Novartis AG, Pfizer Inc., Bayer AG, Astellas Pharma Inc., Celgene Corporation, Bristol-Myers Squibb, F. Hoffmann-La-Roche Ltd., Johnson and Johnson, etc.

  1. Introduction
    1. Product Definition
    2. Research Process
    3. Glossary
    4. Market Segmentation
  2. Executive Summary
  3. Expert Verbatim- Interview Excerpts of industry experts
  4. Impact of COVID-19 on India Cancer Treatment Market
  5. India Cancer Treatment Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Treatment Type
        1. Chemotherapy
        2. Targeted Therapy
        3. Immunotherapy
        4. Hormonal Therapy
        5. Other Treatment Types
      2. By Type
        1. Blood Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Prostate Cancer
        6. Gastrointestinal Cancer
        7. Gynecologic Cancer
        8. Non-Hodgkin’s Cancer
        9. Respiratory/ Lung Cancer
        10. Stomach Cancer
        11. Other Cancers
      3. By End-Users
        1. Hospitals
        2. Specialty Clinics
        3. Cancer and Radiation Therapy Centers
      4. By Region
        1. North
        2. West
        3. South
        4. East
      5. By Company
        1. Revenue Shares
        2. Strategic Factorial Indexing
        3. Competitor Placement in MarkNtel Quadrant
  6. India Chemotherapy Cancer Treatment Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Type
      2. By End-User
      3. Region
  7. India Targeted Therapy Cancer Treatment Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Type
      2. By End-User
      3. Region
  8. India Immunotherapy Cancer Treatment Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Type
      2. By End-User
      3. Region
  9. India Hormonal Therapy Cancer Treatment Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Type
      2. By End-User
      3. Region
  10. India Cancer Treatment Market Trends & Insights
  11. India Cancer Treatment Market Dynamics
    1. Drivers
    2. Challenges
    3. Impact Analysis
  12. India Cancer Treatment Market Regulations, Product Standards
  13. India Cancer Treatment Market Hotspots & Opportunities
  14. India Cancer Treatment Market Key Strategic Imperatives for Growth & Success
  15. Competition Outlook
    1. Competitor Wise Growth Strategies
      1. Product Portfolio
      2. Brand Specialization
      3. Target Markets
      4. Research & Development
      5. Strategic Alliances & Initiatives
    2. Company Profiles
      1. Amgen 
      2. Natco Pharma
      3. Cipla
      4. AstraZeneca
      5. F. Hoffmann- La- Roche
      6. Astellas
      7. Bristol-Myers Squib 
      8. Merck and Co
      9. Novartis
      10. Pfizer
      11. Bayer
      12. Dr. Reddy's Laboratories
      13. Astellas Pharma 
      14. Celgene
      15. Johnson and Johnson
  16. Disclaimer
India Cancer Treatment Market Segmentation
*This field is required